#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	11892	16S	1529	1529	99.93	16S.l15.c17.ctg.1	1985	589.7	0	.	n	.	0	C1450T	SNP	1450	1450	C	1677	1677	T	676	T,C,G	642,3,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	11892	16S	1529	1529	99.93	16S.l15.c17.ctg.1	1985	589.7	1	SNP	n	C1184T	0	.	.	1184	1184	C	1411	1411	C	698	C,A	686,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	11892	16S	1529	1529	99.93	16S.l15.c17.ctg.1	1985	589.7	0	HET	.	.	.	A800G	.	800	800	A	1027	1027	A	692	A,G	348,331	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22256	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3462	638.0	0	.	n	.	0	G1337A	SNP	1337	1337	G	1662	1662	A	699	A,G	683,3	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22256	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3462	638.0	0	.	n	.	0	T1971C	SNP	1971	1971	T	2296	2296	C	638	C	626	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22256	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3462	638.0	1	SNP	n	A2045G	0	.	.	2045	2045	A	2370	2370	A	703	A	689	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22256	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3462	638.0	1	SNP	n	C2597T	0	.	.	2597	2597	C	2922	2922	C	703	C,T	692,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
blaTEM.WHO_M_pConjugative_00003	blaTEM.WHO_M_pConjugative_00003	1	0	512	24	blaTEM	861	406	99.26	blaTEM.l6.c30.ctg.1	406	1.5	0	.	p	.	0	H94D	NONSYN	280	282	CAC	156	158	GAC	1;1;1	G;A;C	1;0;1	.	Betalactam resistance
blaTEM.WHO_M_pConjugative_00003	blaTEM.WHO_M_pConjugative_00003	1	0	512	24	blaTEM	861	75	100.0	blaTEM.l6.c30.ctg.2	288	1.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Betalactam resistance
blaTEM.WHO_M_pConjugative_00003	blaTEM.WHO_M_pConjugative_00003	1	0	512	24	blaTEM	861	123	100.0	blaTEM.l6.c30.ctg.3	389	2.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Betalactam resistance
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	1472	folP	855	855	100.0	folP.l15.c4.ctg.1	1522	95.9	1	SNP	p	R229S	1	.	.	685	687	AGC	974	976	AGC	159;160;161	A;G;C	155;154;155	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4570	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3382	134.0	1	SNP	p	S91F	1	.	.	271	273	TTC	539	541	TTC	160;159;160	T;T;C	159;157;158	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4570	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3382	134.0	1	SNP	p	D95G	1	.	.	283	285	GGC	551	553	GGC	154;153;148	G;G;C,T	153;150;144,1	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4570	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3382	134.0	1	SNP	p	G95N	0	.	.	283	285	GGC	551	553	GGC	154;153;148	G;G;C,T	153;150;144,1	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	27	1528	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1410	107.0	1	SNP	p	G45D	0	.	.	133	135	GGC	563	565	GGC	195;191;191	G;G;C,G	189;183;183,1	mtrR.WHO_G_01393:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	820	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1073	75.9	0	.	n	.	0	A197.	DEL	197	197	A	567	567	A	176	A	174	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	4014	parC	2304	2304	99.87	parC.l15.c4.ctg.1	2946	135.4	0	.	p	.	0	I384V	NONSYN	1150	1152	ATC	1468	1470	GTC	160;159;160	G;T;C	158;156;157	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	4014	parC	2304	2304	99.87	parC.l15.c4.ctg.1	2946	135.4	1	SNP	p	D86N	0	.	.	256	258	GAC	574	576	GAC	150;150;151	G;A;C	147;144;150	parC.WHO_V_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	4014	parC	2304	2304	99.87	parC.l15.c4.ctg.1	2946	135.4	1	SNP	p	R87I	0	.	.	259	261	CGT	577	579	CGT	149;150;153	C;G;T	148;149;151	parC.WHO_V_00204c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	4014	parC	2304	2304	99.87	parC.l15.c4.ctg.1	2946	135.4	1	SNP	p	S87R	1	.	.	259	261	CGT	577	579	CGT	149;150;153	C;G;T	148;149;151	parC.WHO_V_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	4014	parC	2304	2304	99.87	parC.l15.c4.ctg.1	2946	135.4	1	SNP	p	R87W	0	.	.	259	261	CGT	577	579	CGT	149;150;153	C;G;T	148;149;151	parC.WHO_V_00204c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	4014	parC	2304	2304	99.87	parC.l15.c4.ctg.1	2946	135.4	1	SNP	p	S88P	0	.	.	262	264	TCC	580	582	TCC	153;154;151	T;C,T;C	151;151,1;150	parC.WHO_V_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	3460	parE	1986	1986	99.95	parE.l15.c4.ctg.1	2618	131.2	0	.	p	.	0	R340C	NONSYN	1018	1020	CGC	1373	1375	TGC	148;149;148	T,C;G;C	139,1;148;146	.	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	3460	parE	1986	1986	99.95	parE.l15.c4.ctg.1	2618	131.2	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1583	1585	GGC	172;169;168	G;G;C	167;165;160	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.12.001	penA.12.001	1	1	27	3090	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2516	121.8	1	SNP	p	A311V	0	.	.	931	933	GCA	1263	1265	GCA	154;154;158	G;C;A	147;151;155	penA.12.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	3090	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2516	121.8	1	SNP	p	I312M	0	.	.	934	936	ATC	1266	1268	ATC	158;158;155	A;T;C	155;154;149	penA.12.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	3090	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2516	121.8	1	SNP	p	V316T	0	.	.	946	948	GTG	1278	1280	GTG	164;163;165	G;T;G	161;157;161	penA.12.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	3090	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2516	121.8	1	SNP	p	V316P	0	.	.	946	948	GTG	1278	1280	GTG	164;163;165	G;T;G	161;157;161	penA.12.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	3090	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2516	121.8	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1782	1784	ACC	168;168;170	A;C;C	158;164;165	penA.12.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	3090	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2516	121.8	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1836	1838	GCG	150;147;148	G;C,G;G	137;118,3;136	penA.12.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	3090	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2516	121.8	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1836	1838	GCG	150;147;148	G;C,G;G	137;118,3;136	penA.12.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	3090	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2516	121.8	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1959	1961	GGC	94;93;93	G;G;C,T	93;91;90,1	penA.12.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	3090	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2516	121.8	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1968	1970	GGC	98;97;96	G;G;C	96;94;93	penA.12.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	3090	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2516	121.8	1	SNP	p	P552S	1	.	.	1654	1656	TCG	1986	1988	TCG	96;97;96	T,G,C;C;G,C	60,17,1;86;85,1	penA.12.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	4726	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3190	147.3	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1698	1700	CCG	172;172;169	C;C;G	156;164;157	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2190	porA	1146	1146	99.56	porA.l15.c4.ctg.1	1886	115.0	0	.	p	.	0	M83fs	FSHIFT	247	247	A	561	561	C	153	C,G	140,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2156	porB1b	1047	1047	99.33	porB1b.l6.c4.ctg.1	1487	143.3	0	.	p	.	0	N38E	NONSYN	112	114	AAT	351	353	GAA	171;173;176	G;A;A,G	166;168;169,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2156	porB1b	1047	1047	99.33	porB1b.l6.c4.ctg.1	1487	143.3	0	.	p	.	0	N134D	NONSYN	400	402	AAT	639	641	GAT	152;151;156	G,A;A;T	147,1;147;152	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2156	porB1b	1047	1047	99.33	porB1b.l6.c4.ctg.1	1487	143.3	0	.	p	.	0	P175S	NONSYN	523	525	CCA	762	764	TCA	170;172;174	T;C;A	162;169;169	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2156	porB1b	1047	1047	99.33	porB1b.l6.c4.ctg.1	1487	143.3	0	.	p	.	0	A218V	NONSYN	652	654	GCC	891	893	GTC	184;185;183	G,A;T;C	176,1;177;177	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2156	porB1b	1047	1047	99.33	porB1b.l6.c4.ctg.1	1487	143.3	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1221	1223	GCA	168;169;170	G;C;A	165;167;167	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2156	porB1b	1047	1047	99.33	porB1b.l6.c4.ctg.1	1487	143.3	1	SNP	p	G120K	1	.	.	358	360	AAG	597	599	AAG	152;151;151	A;A,T;G	150;149,1;148	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2156	porB1b	1047	1047	99.33	porB1b.l6.c4.ctg.1	1487	143.3	1	SNP	p	A121D	1	.	.	361	363	GAC	600	602	GAC	153;151;153	G,A;A,G;C	151,1;147,1;151	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2156	porB1b	1047	1047	99.33	porB1b.l6.c4.ctg.1	1487	143.3	1	SNP	p	D121N	0	.	.	361	363	GAC	600	602	GAC	153;151;153	G,A;A,G;C	151,1;147,1;151	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	7990	rpoB	4179	4179	100.0	rpoB.l15.c17.ctg.1	4828	164.3	1	SNP	p	H553N	1	.	.	1657	1659	AAT	1994	1996	AAT	166;167;168	A;A;T	163;163;166	rpoB.WHO_M_02157:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	920	rpsJ	312	312	100.0	rpsJ.l15.c30.ctg.1	1007	90.6	1	SNP	p	V57M	1	.	.	169	171	ATG	530	532	ATG	178;179;181	A;T;G	174;174;176	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
